![Expected outcomes and patients' selection before chemoembolization—“Six-and-Twelve or Pre-TACE-Predict” scores may help clinicians: Real-life French cohorts results Expected outcomes and patients' selection before chemoembolization—“Six-and-Twelve or Pre-TACE-Predict” scores may help clinicians: Real-life French cohorts results](https://f6publishing.blob.core.windows.net/1f222ac9-964e-46a4-af57-43f89f889b4f/WJCC-9-4559-g004.png)
Expected outcomes and patients' selection before chemoembolization—“Six-and-Twelve or Pre-TACE-Predict” scores may help clinicians: Real-life French cohorts results
![JPM | Free Full-Text | Transarterial Chemoembolization for Hepatocellular Carcinoma: Why, When, How? JPM | Free Full-Text | Transarterial Chemoembolization for Hepatocellular Carcinoma: Why, When, How?](https://www.mdpi.com/jpm/jpm-12-00436/article_deploy/html/images/jpm-12-00436-g001.png)
JPM | Free Full-Text | Transarterial Chemoembolization for Hepatocellular Carcinoma: Why, When, How?
![Efficacy of adjuvant TACE on the prognosis of patients with HCC after hepatectomy: a multicenter propensity score matching from China | BMC Cancer | Full Text Efficacy of adjuvant TACE on the prognosis of patients with HCC after hepatectomy: a multicenter propensity score matching from China | BMC Cancer | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12885-023-10802-9/MediaObjects/12885_2023_10802_Fig2_HTML.png)
Efficacy of adjuvant TACE on the prognosis of patients with HCC after hepatectomy: a multicenter propensity score matching from China | BMC Cancer | Full Text
![The “Six-and-Twelve” Score for Recurrent HCC Patients Receiving TACE: Does it Still Work? | SpringerLink The “Six-and-Twelve” Score for Recurrent HCC Patients Receiving TACE: Does it Still Work? | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs00270-021-02791-8/MediaObjects/270_2021_2791_Fig1_HTML.png)
The “Six-and-Twelve” Score for Recurrent HCC Patients Receiving TACE: Does it Still Work? | SpringerLink
![HAP score as prognostic factor of hepatocellular carcinoma treated with transarterial chemoembolization in a Latin American center HAP score as prognostic factor of hepatocellular carcinoma treated with transarterial chemoembolization in a Latin American center](http://www.scielo.org.pe/img/revistas/rgp/v38n2/a09tab02.jpg)
HAP score as prognostic factor of hepatocellular carcinoma treated with transarterial chemoembolization in a Latin American center
![Feasibility of dynamic risk assessment for patients with repeated trans-arterial chemoembolization for hepatocellular carcinoma | BMC Cancer | Full Text Feasibility of dynamic risk assessment for patients with repeated trans-arterial chemoembolization for hepatocellular carcinoma | BMC Cancer | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12885-019-5495-6/MediaObjects/12885_2019_5495_Fig3_HTML.png)
Feasibility of dynamic risk assessment for patients with repeated trans-arterial chemoembolization for hepatocellular carcinoma | BMC Cancer | Full Text
![Development and validation of a novel online calculator for estimating survival benefit of adjuvant transcatheter arterial chemoembolization in patients undergoing surgery for hepatocellular carcinoma | Journal of Hematology & Oncology | Full Text Development and validation of a novel online calculator for estimating survival benefit of adjuvant transcatheter arterial chemoembolization in patients undergoing surgery for hepatocellular carcinoma | Journal of Hematology & Oncology | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13045-021-01180-5/MediaObjects/13045_2021_1180_Fig1_HTML.png)